M&A Deal Summary |
|
|---|---|
| Date | 2024-12-23 |
| Target | RLS Radiopharmacies |
| Sector | Life Science |
| Buyer(s) | Telix Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 230M USD |
SEARCH BY
Telix Pharmaceuticals Ltd. is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 7 |
| Sector: Life Science M&A | 5 of 6 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 4 of 5 |
| Year: 2024 M&A | 4 of 4 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-05 |
Artms
Burnaby, British Columbia, Canada Artms is a commercial-stage company that specializes in the physics, chemistry, and materials science of cyclotron-produced radionuclides. Its technology is used by the major manufacturing networks to optimize the production of a range of medical radioisotopes. Artms is based in Burnaby, British Columbia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-01-22 |
ImaginAb - Therapeutic Pipeline
Inglewood, California, United States ImaginAb's Therapeutic Pipeline is a proprietary novel biologics technology platform. |
Buy | - |
